DSpace Repository

Do tofacitinib generics exhibit conventional synthetic disease-modifying anti-rheumatic drug and non-steroidal anti-inflammatory drug-sparing ability in the management of axial spondyloarthritis

Files in this item

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account